Pre-ECT Investigations and Guidelines

Introduction to Pre-ECT Evaluations

The American Academy of Child and Adolescent Psychiatry recommends that every patient considered for ECT must receive a comprehensive physical evaluation to identify any relative contraindications 1, 3
A comprehensive set of investigations must be completed before proceeding with electroconvulsive therapy (ECT), including a thorough physical examination, laboratory tests, cognitive assessment, and psychiatric evaluation to ensure patient safety and optimize outcomes 1, 2

The American Academy of Child and Adolescent Psychiatry suggests that laboratory investigations are dictated by clinical assessment and must include complete blood count with differential white blood cell count, thyroid function tests, liver function tests, urinalysis and toxicology screen, electrocardiogram (ECG), and serum or urine pregnancy test for all female patients 2, 3
Neuroimaging studies, such as electroencephalogram (EEG), computed tomography (CT), or magnetic resonance imaging (MRI) of the brain, may be indicated in certain cases 2, 3

A detailed clinical interview documenting target symptoms using reliable rating instruments is necessary, along with collateral information from parents or other informants, assessment of illness severity, and review of past treatments 1, 3
The review of past treatments should include documentation of previous pharmacotherapy, verification of medication adherence, and review of psychotherapeutic treatments and psychosocial interventions 2

Memory assessment must be performed before treatment, serving as a baseline for comparison with post-treatment assessments 2, 3
This baseline assessment is crucial for evaluating the cognitive effects of ECT 2, 3

Standard procedure requires consultation with an anesthesiologist, preferably one experienced in treating the patient population, and additional specialist consultations should be obtained if there is evidence of concurrent medical pathology 4, 5
Review and documentation of all current medications, consideration of discontinuing medications that may interfere with ECT, and special attention to medications that may affect seizure threshold, such as benzodiazepines, theophylline, and carbamazepine, are necessary 2, 4, 5

Written informed consent must be obtained, and education regarding the procedure, risks, and benefits must be provided, with familiarity with state and institutional guidelines regarding ECT 2, 6
An independent evaluation from a psychiatrist knowledgeable about ECT and not directly responsible for the patient's treatment is recommended to review the diagnosis, confirm illness severity and treatment resistance, corroborate the advisability of ECT, and review the adequacy of the pre-ECT workup 2, 6

Failing to identify relative contraindications, inadequate documentation of previous treatment failures, overlooking the need for pregnancy testing in female patients, insufficient cognitive assessment before treatment, and not obtaining appropriate specialist consultations when concurrent physical illness is present should be avoided 1, 2, 3, 4, 5